TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00724477 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03852147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02511782 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT05345236 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01313273 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03760848 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03518905 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT04008498 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01930227 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01956786 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03824119 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01108094 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study NCT01954394 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03943238 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04294979 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT00002804 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04507711 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01081613 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01081613 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03533998 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04863768 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00550563 — Predictive Biomarker (PRD): CYP24A1 mRNA
Genes: CYP24A1; CYP24
Study NCT03352089 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01586611 — Predictive Biomarker (PRD): Solute carrier family 29 member 1
Genes: SLC29A1; ENT1
Study NCT00594685 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT02115100 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00286754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02052947 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04821401 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01587729 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01139320 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03089372 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT03443596 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00162474 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00949585 — Surrogate Endpoint (SUR): Serum potassium
Study NCT03475030 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04622566 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03830268 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02575222 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00550537 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02286076 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01457118 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT02443961 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02089997 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04249271 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03380377 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00767572 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02932345 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01265225 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT01265225 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT01265225 — Predictive Biomarker (PRD): PROCR mRNA
Genes: PROCR; EPCR
Study NCT01278732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02155465 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00583310 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03839563 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03839563 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03839563 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03839563 — Safety Biomarker (SAF): BDNF
Study NCT03839563 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00089661 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00904345 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00904345 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00972218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04485013 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01327222 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01831895 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02960568 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02997150 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03909945 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03909945 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01458808 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03537872 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03821545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01516983 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03446339 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02903901 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04083560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00800709 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03241784 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03241784 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04537338 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03615625 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02730611 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT04698889 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03437694 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02514941 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02514941 — Predictive Biomarker (PRD): ABCC2 mRNA
Genes: ABCC2; CMOAT; CMOAT1; CMRP; MRP2
Study NCT02468258 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02468258 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01593007 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02666755 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02666755 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01364961 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT03550781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03550781 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03550781 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study NCT03550781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03550781 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT03550781 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03550781 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT03550781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03292354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04054544 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00300911 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04395417 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02770820 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02409472 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04305236 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00878878 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT00878878 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01947218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01947218 — Predictive Biomarker (PRD): FOXA2 mRNA
Genes: FOXA2; HNF3B; TCF3B
Study NCT01947218 — Predictive Biomarker (PRD): SPDEF mRNA
Genes: SPDEF; PDEF; PSE
Study NCT01947218 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00747864 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT03233724 — Predictive Biomarker (PRD): AADAC mRNA
Genes: AADAC; DAC
Study NCT03806296 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT01132677 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03481998 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03481998 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01350960 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT03004105 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00089193 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02973763 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02973763 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03122990 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03122990 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02357732 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02238990 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02373319 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02042664 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03854942 — Safety Biomarker (SAF): DRD2
Study NCT00385346 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT02076763 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT01291121 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04398745 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04239833 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03314688 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03314688 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03314688 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02109250 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT03984448 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT03984448 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT01945164 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01945164 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01945164 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01945164 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT01945164 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT01945164 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT01945164 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00001865 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00609830 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00846274 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT00526734 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00526734 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01810042 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03962686 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03962686 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT03962686 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01013467 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03020615 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00056134 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04140435 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04475861 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT03872947 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT03872947 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01331538 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study NCT04361786 — Predictive Biomarker (PRD): TREX1 mRNA
Genes: TREX1
Study NCT02289963 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02289963 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03723395 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03723395 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00987948 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00987948 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT00987948 — Surrogate Endpoint (SUR): Undetectable plasma HIV RNA
Study NCT03135743 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03350152 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01827163 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01688609 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01688609 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04669041 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04000815 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT04000815 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT02642068 — Predictive Biomarker (PRD): SLC6A2 mRNA
Genes: SLC6A2; NAT1; NET1; SLC6A5
Study NCT04191005 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT01328561 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT04370639 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02882945 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study NCT01751048 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT00159510 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00091052 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00630149 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00630149 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT02132234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02132234 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01108211 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02017223 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01629433 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT01629433 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT01629433 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT04598581 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02987764 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00005164 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05355558 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02627066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03251911 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02109692 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02109692 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT01262469 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01376713 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03318601 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01832259 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01832259 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01832259 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04437706 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01875952 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00437658 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03571997 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04534166 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03548675 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03548675 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03663270 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02822326 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01513174 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01513174 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01517854 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05458635 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02100761 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04938518 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03453476 — Safety Biomarker (SAF): Interleukin 1
Study NCT03453476 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03453476 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03453476 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03453476 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT04146766 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04701541 — Predictive Biomarker (PRD): DIAPH2 mRNA
Genes: DIAPH2; DIA
Study NCT00001774 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT02444715 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04518059 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT02273752 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03357003 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00903032 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00903032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00903032 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03851965 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT01310920 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study NCT03638128 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00442286 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01392430 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02006043 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04366401 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02609256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02823522 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04074915 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03119025 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03847350 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01498003 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT01086254 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT01745120 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02018315 — Predictive Biomarker (PRD): SLC25A20 mRNA
Genes: SLC25A20; CAC; CACT
Study NCT01899495 — Predictive Biomarker (PRD): SLC4A5 mRNA
Genes: SLC4A5; NBC4
Study NCT01481649 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00441831 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP